期刊论文详细信息
Archives of Public Health
Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis
Ezra Belay Ketema1  Kelemu Tilahun Kibret2 
[1] Department of Biochemistry, College of Health Science, Mekelle University, Mekelle, Ethiopia
[2] Department of Public Health, College of Medical and Health Science, Wollega University, Nekemte, Ethiopia
关键词: Correlation;    Postprandial plasma glucose;    Fasting plasma glucose;    HbA1c;    Glycemic control;    Diabetes mellitus;   
Others  :  1230582
DOI  :  10.1186/s13690-015-0088-6
 received in 2015-06-15, accepted in 2015-08-04,  发布年份 2015
PDF
【 摘 要 】

Background

Glycemic control in diabetes mellitus is a cornerstone in reducing morbidity and mortality of the disease. Achieving glycemic control or reducing hyperglycemia significantly decreases the microvascular and macrovascular complications of diabetes. Even though measurement of glycated hemoglobin (HbA1c) remains the gold standard for assessment of glycemic control, there is no consensus whether fasting or postprandial plasma glucose (PPG) is a better predictor of glycemic control in resource-poor settings when HbA1c is not available. The aim of this systematic review and meta-analysis was to summarize evidences on the significance of fasting and postprandial plasma glucose, and their correlation with HbA1c.

Methods

Relevant studies were identified through systematic search of online databases (e.g. EMBASE, MEDLINE/PubMed and Cochrane library) and manual search of bibliographies of the included studies. Original research papers describing the correlations or associations of fasting and postprandial plasma glucose with HbA1c were included. The MedCalc software was used for data entry and analysis. We used the random effect model to estimate the pooled correlations of fasting and postprandial plasma glucose with HbA1c. Heterogeneity assessment and robustness analysis was also performed.

Result

From total 126 articles identified, 14 articles were eligible for systemic review. Eleven of these eligible studies evaluated the correlations of fasting and postprandial plasma glucose to the standard HbA1c values and used in meta-analysis. Seven of these studies (63.5 %) found better or stronger correlations between PPG and HbA1c than fasting plasma glucose (FPG). In all the studies that estimated the relative contribution FPG and PPG to the overall hyperglycemia, decreases in PPG was accounted for greater decrease in HbA1c compared with decreases in FPG value. PPG also showed a better sensitivity, specificity and positive predictive value than FPG. The pooled correlation coefficient (r) between PPG and HbA1c was 0.68 (P < 0.001, 95 % CI; 0.56–0.75) slightly higher than pooled correlation coefficient of FPG (r = 0.61(P < 0.001, 95 % CI; 0.48–0.72)).

Conclusion

PPG has a closer association with HbA1c than FPG. Hence, PPG is better in predicting overall glycemic control in the absence of HbA1c.

【 授权许可】

   
2015 Ketema and Kibret.

【 预 览 】
附件列表
Files Size Format View
20151107011248323.pdf 873KB PDF download
Fig. 3. 43KB Image download
Fig. 2. 35KB Image download
Fig. 1. 42KB Image download
【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

【 参考文献 】
  • [1]American Diabetes Association: Standards of medical care in diabetes Diabetes Care 2014, 37:S14-S80.
  • [2]Sarah JB, Soma SN, Margaret J, Jeremy M, Shiva S, Charles M. Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. Diabetes Care. 2004;27:694–8.
  • [3]Vinod Mahato R, Gyawali P, Raut PP, Regmi P, Singh KP, Raj Pandeya DP, et al. Association between glycaemic control and serum lipid profile in type 2 diabetic patients: Glycated haemoglobin as a dual biomarker. Biomedical Researchm. 2011;22(3):375–80.
  • [4]UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 1998, 352:837-53.
  • [5]The Diabetes Control and Complications Trial Research Group: The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial Diabetes 1995, 44:968-83.
  • [6]Swetha NK: Comparison of fasting blood glucose & post prandial blood glucose with HbA1c in assessing the glycemic control. International J of Healthcare and Biomedical Research 2014, 2(3):134-139.
  • [7]Ghazanfari Z, Haghdoost AA, Alizadeh SM, Atapour J, Zolala F. A comparison of HbA1c and fasting blood sugar tests in general population. Int J Prev Med. 2010;1(3):187–94.
  • [8]Weykamp C, Garry John W, Mosca A: A review of the challenge in measuring hemoglobin A1c..journal of diabetes. Sci. Technol. 2009, 3(3):439-45.
  • [9]Pasupathi P, Manivannan P M, Uma M, Deepa M. Glycated haemoglobin (HbA1c) as a stable indicator of type 2 diabetes Int J Pharm. Biomed Res. 2010;1(2):53–6.
  • [10]Ken S: The correlation of hemoglobin A1c to blood glucose. J Diabetes Sci Technol 2009, 3(3):429-38.
  • [11]Canadian Diabetes Association: Clinical practice guidelines: targets for glycemic control Can J Diabetes 2013, 37:S31eS34.
  • [12]Monnier L, Lapinski H, Colette C: Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA (1c). Diabetes Care 2003, 26:481-85.
  • [13]Rosediani M, Azidah AK, Mafauzy M: Correlation Between Fasting Plasma Glucose, Post Prandial Glucose and Glycated Haemoglobin and Fructosamine. Med JMalaysia 2006, 61(1):67-71.
  • [14]Weerarathne TP, Dissanayake AS: Value of assessing post prandial blood glucose as a surrogate for fasting blood glucose in an outpatient medical clinic: a descriptive study. Galle Medical Journal 2006, 11(1):06-09.
  • [15]Sheppard P, Bending JJ, Huber JW. Pre- and post-prandial capillary glucose self-monitoring achieves better glycaemic control than pre-prandial only monitoring: A study in insulin treated diabetic patients. Practical Diabetes Int. 2005;22(1):15–22.
  • [16]Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM. Cochrane Diagnostic Test Accuracy Working Group. Systematic reviews of diagnostic test accuracy Ann Intern Med. 2008;149:889–97.
  • [17]Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med, 2009;6(7):e1000097.
  • [18]Kohnert KD, et al.: Utility of different glycemic control metrics for optimizing management of diabetes. World J Diabetes 2015, 6(1):17-29.
  • [19]Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to meta-analysis. 1st ed. West Sussex, United Kingdom: John Wiley & Sons Ltd. Chichester; 2009.
  • [20]Saed MK: Postprandial blood glucose as a marker of glycemic control in type 2 sudanese diabetics sudanese. jpublic health 2006, 4(1):278-88.
  • [21]Haddadinezhad S, Ghazaleh N: Relation of fasting and postprandial and plasm glucose to hemoglobin A1c in diabetics. Int J Diab dev ctries 2010, 30(1):8-10.
  • [22]Gupta S, Puppalwar PV, Chalak A: Correlation of fasting and post meal plasma glucose level to increased HbA1c levels in type-2 diabetes mellitus. Int J Adv Med 2014, 1:127-31.
  • [23]Datta S, Pal M, Mitra R, Ganguly A, Basu S, Manna s. Value of assessing post prandial and fasting plasma glucose as a surrogate for glycated hemoglobin in diabetic glycemic control. World Journal of Pharmaceutical Research. 2014;3(9):494–503.
  • [24]Avignon A, Radauceanu A, Monnier L: Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 1997, 20:1822.1826.
  • [25]Bonora E, Francesco C, Simonetta L, Bonfante N. Plasma glucose levels throughout the day and HbA1c interrelationships in type 2 diabetes: Implications for treatment and monitoring of metabolic control. Diabetes Care. 2001;24:2023–9.
  • [26]Shrestha L, et al.: Correlation between fasting blood glucose, postprandial blood glucose and glycated hemoglobin in non insulin treated type 2 diabetic subjects. Sunsari Technical College Journal 2012, 1(1):18-21.
  • [27]Azim W, Mushtaq Gill M, Azim S, Farooq W. Assessment of fasting and two-hour post-prandial glucose as an economical test for monitoring of glycemic control, compared to glycated haemoglobin. Med Channel., 2011;17(2):5–7.
  • [28]Saiedullah M, Hayat S, Kamaluddin SM, Begum S. Correlation of Fasting and Post Prandial Plasma Glucose with Hemoglobin Glycation. AKMMC J. 2013;4(2):28–30.
  • [29]Woerle HJ, Neumann C, Zschau S, Tenner S, Irsigler A, Schirra J, et al. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels. Diabetes Res Clin Pract. 2007;77:280–5.
  • [30]Schernthaner G, Guerci B, Gallwitz L, Rosediani M, Nicolay C, Kraus P, et al. Impact of postprandial and fasting glucose concentration on HbA1c in pateints with type 2 diabetes. Diabetes Metab. 2010;36:389–94.
  • [31]Ceriello A, Colagiuri S, Gerich J, Tuomilehto J. Guideline for management of postmeal glucose. Nutr Metab Cardiovasc Dis. 2008;18(4):S17–33.
  • [32]Sharon H, Judith F, Catherine C: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. J. Am. Med. Assoc. 2004, 291:335-342.
  • [33]Kilpatrick ES: Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus. J Clin Pathol 2008, 61(9):977-82.
  • [34]Bloomgarden ZT: A1c: recommendations, debates, and questions. Diabetes Care 2009, 32(12):141-7.
  • [35]Kohnert KD, Augstein P, Heinke P, Zander E, Peterson K, Freyse EJ, et al. Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes. Diabetes Res Clin Pract. 2007;77:420–6.
  • [36]Haffner S: The importance of postprandial hyperglycaemia in development of cardiovascular disease in people with diabetes. Int J Clin Pract 2001, 123(suppl):24-26.
  • [37]International Diabetes Federation, 2011 Guideline for Management of PostMeal Glucose in Diabetes. 2011;1–37.
  • [38]Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J. 2004;25(1):10–6.
  • [39]Kovatchev B, Cox DJ, Summers KH, Gonder-Frederick L, Clarke WL. Postprandial glucose dynamics and associated symptoms in type 2 diabetes mellitus. The Journal of Applied Research. 2003;3(4):449–58.
  • [40]Szoke E, Shrayyef MZ, Messing S. Effect of aging on glucose homeostasis: accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance. Diabetes Care. 2008;31:539–43.
  • [41]Monnier L, Colette C: Target for glycemic control:concentrating on glucose. Diabetes Care 2009, 32(2):s199-s204.
  文献评价指标  
  下载次数:38次 浏览次数:11次